MITO-7: Weekly chemotherapy in ovarian cancer Last updated on Apr 21, 2024 Previous BEATcc: Atezolizumab added to Cis/Taxol/Bev in recurrent/metastatic cervical cancer Next NRG GY018: Pembrolizumab in Advanced Endometrial Cancer
